Tumor-specific deposition of immunoglobulin G and complement in papillary thyroid carcinoma

Human Pathology
S D LucasC Juhlin

Abstract

Despite its predilection for multifocal growth and regional metastasis, papillary thyroid carcinoma (PTC) is a clinically indolent malignancy with an exceptionally favorable long-term prognosis. Together with the often striking inflammatory reaction present in PTC, its quiescent behavior has been suggested to reflect the activation of a tumor-induced immune response. To examine this possibility, we have studied the deposition of immunoglobulins and complement in PTC tissue. Samples from 70 cases of neoplastic and autoimmune thyroid diseases, including PTC (n = 41), follicular, anaplastic, and medullary carcinomas (n = 12), follicular adenoma (n = 6), Graves' disease (n = 8), and Hashimoto's thyroiditis (n = 3) were analyzed immunohistochemically. Cellular deposits of immunoglobulin G (IgG), particularly subclasses IgG1 and IgG4, and complement factors C3d, C4d, and C5 were shown in up to 80% of the PTC cases, whereas the other thyroid diseases studied showed little or no cellular deposition. Nonneoplastic tissue of PTC-containing thyroid glands (n = 22) lacked staining for IgG in 50% of the cases, and 82% were devoid of complement. The results suggest a tumor-specific immune response in PTC with activation of the classical comp...Continue Reading

References

Sep 1, 1991·Immunology Today·T Kinoshita
Jul 15, 1991·Annals of Internal Medicine·J RobbinsJ Reynolds
May 1, 1986·The Journal of Clinical Endocrinology and Metabolism·T F DaviesM Platzer
Mar 1, 1989·Immunology Today·M W FangerP M Guyre
Mar 15, 1995·Journal of the National Cancer Institute·Y YamashitaM Sowa
May 23, 1995·Proceedings of the National Academy of Sciences of the United States of America·J FagerbergH Mellstedt
Jan 1, 1995·Journal of Molecular Recognition : JMR·G N Misevic, O Popescu
Sep 12, 1995·Proceedings of the National Academy of Sciences of the United States of America·M YoshimuraN Taniguchi
Apr 1, 1995·Endocrine Journal·C TanimotoZ Ota
Jan 1, 1995·Baillière's Clinical Endocrinology and Metabolism·A P Weetman
Apr 1, 1994·International Journal of Cancer. Journal International Du Cancer·G W DentonR A Robins
Feb 1, 1955·A.M.A. Archives of Surgery·M E DAILEYR SKAHEN
Jul 1, 1959·Cancer·G H KLINCK, T WINSHIP

❮ Previous
Next ❯

Citations

Jul 11, 2012·Immunology and Cell Biology·Emma KempshallAwen Gallimore
Sep 13, 2011·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Yamei QiuJiang Gu
Dec 4, 2012·BMC Cancer·Katri MäkeläTimo Paavonen
Aug 21, 2015·Annals of Surgical Oncology·Stephanie Downs-CannerDavid L Bartlett
Jun 19, 2007·Immunology Letters·Paolo Macor, Francesco Tedesco
Jul 11, 2012·Clinical and Experimental Immunology·L LiuM Kirschfink
May 28, 2013·Seminars in Immunology·Ruben PioJohn D Lambris
Jul 23, 2015·Journal of Biomedical Science·M Afzal KhanD C Broering
Mar 15, 2006·Neoplasia : an International Journal for Oncology Research·Robert D LobergKenneth J Pienta
Jan 27, 2015·Annual Review of Immunology·Seng-Ryong WooThomas F Gajewski
Sep 30, 2016·Journal of Pathology and Translational Medicine·Seok Woo YangSoon Won Hong
Oct 27, 2016·Immunological Reviews·Pedro BerraondoRuben Pio
Nov 8, 2016·Functional & Integrative Genomics·Bugra Ozer, Ugur Sezerman
Jun 21, 2002·International Journal of Surgical Pathology·Dalal M Tamimi
Oct 23, 1997·International Journal of Cancer. Journal International Du Cancer·S D LucasC Juhlin
Feb 24, 2005·British Journal of Cancer·L BjørgeS Meri
May 8, 2018·Scandinavian Journal of Immunology·H Bareke, J Akbuga
Jul 31, 2018·The International Journal of Biological Markers·Reyhaneh Farrokhi YektaAhmad R Soroush
Aug 24, 2001·International Journal of Cancer. Journal International Du Cancer·K JurianzM Kirschfink
Oct 26, 2018·International Journal of Cancer. Journal International Du Cancer·Eyun SongTae Yong Kim
May 28, 2009·Journal of Gynecologic Oncology·Dae Hoon JeongKi Tae Kim
Nov 2, 2019·Nature Reviews. Cancer·Lubka T RoumeninaWolf Herman Fridman
Oct 1, 2011·Archivum Immunologiae Et Therapiae Experimentalis·Martin KolevRossen Donev
May 14, 2014·Molecular Medicine Reports·Kailong LinBo Zhu
May 27, 2016·The Journal of Biological Chemistry·Laurence D TownerB Paul Morgan
Apr 20, 2019·Frontiers in Immunology·Daniel AjonaFernando Lecanda
May 3, 2019·The British Journal of Dermatology·P RiihiläV-M Kähäri
Aug 1, 2018·Frontiers in Immunology·Dawn M KochanekMaciej M Markiewski
Apr 10, 2019·Endocrine Connections·Eugenie S LimMaralyn Druce
May 21, 2004·Journal of Gastroenterology and Hepatology·Kimihiro ShimoYasushi Shiratori
Oct 30, 2020·Antibodies·Margot RevelLubka T Roumenina
Feb 26, 2021·Oncoimmunology·Galateja JordakievaErika Jensen-Jarolim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.

Autoimmune Thyroiditis

Autoimmune thyroiditis is an inflammatory disease of thyroid gland due to autoimmune responses leading to lymphocytic infiltration of the gland. It is characterized by the presence of circulating thyroid antigen-specific T-cells and thyroid autoantibodies. Discover the latest research on autoimmune thyroiditis here.